The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Pfizer .

Filed returns
57
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2016: 1 filed returns Jan–Apr 2017: 2 filed returns May–Aug 2017: 2 filed returns Sep–Dec 2017: 2 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2020: 3 filed returns Sep–Dec 2020: 3 filed returns Jan–Apr 2021: 3 filed returns May–Aug 2021: 3 filed returns Sep–Dec 2021: 4 filed returns Jan–Apr 2022: 2 filed returns May–Aug 2022: 3 filed returns Sep–Dec 2022: 4 filed returns Jan–Apr 2023: 4 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 1 filed returns Jan–Apr 2024: 2 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 3 filed returns Jan–Apr 2025: 4 filed returns May–Aug 2025: 2 filed returns Sep–Dec 2025: 2 filed returns Jan–Apr 2026: 2 filed returns 2017 2018 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2017 Pfizer Health Pfizer is seeking reimbursement for a new treatment for metatastic breast cancer which is reimbursed in the majority of EU countries but not yet in Ireland. Ireland has become one of the slowest countries in Europe to… (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2017 Pfizer Economic Development and Industry Global competition for foreign direct investment continues to intensify and Ireland continues to compete for such investment. Pfizer has extensive operations in Ireland where many of Pfizer's leading and newest… (Public policy or programme) 4 On lobbying.ie
May–Aug 2017 Pfizer Health Ireland has now become one of the slowest countries in Europe to reimburse innovative medicines for patients. HTA assessment is prolonged and decisions after HTA are exceptionally slow with the majority of medicines… (Public policy or programme) 12 On lobbying.ie
May–Aug 2017 Pfizer Economic Development and Industry The Companies Act 2014 allowed for a Ministerial exemption from changing a company name to include the word 'unlimited' in the company name. This change would create significant administrative and cost burden for five… (Legislation) 11 On lobbying.ie
Jan–Apr 2017 Pfizer Economic Development and Industry Global competition for FDI and life sciences investment continues to intensify and Ireland continues to compete for such investment. Pfizer has extensive operations in Ireland where many of Pfizer's leading and newest… (Public policy or programme) 7 On lobbying.ie
Jan–Apr 2017 Pfizer Economic Development and Industry The Companies Act 2014 allowed for a Ministerial exemption from changing a company name to include the word 'unlimited' in the company name. This change would create significant administrative and cost burden for five… (Legislation) 17 On lobbying.ie
May–Aug 2016 Pfizer Health A Supply Agreement between the pharmaceutical industry and the goverment expired and a new Agreement was to be negotiated between the pharmaceutical industry and the DoH/State. (Public policy or programme) 5 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 26 45.6%
Economic Development and Industry 14 24.6%
EU Affairs 10 17.5%
Trade 3 5.3%
Budgetary matters 2 3.5%
Energy and Natural Resources 1 1.8%
Taxation 1 1.8%